nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A role for membrane potential in regulating GPCRs?
|
Mahaut-Smith, Martyn P. |
|
2008 |
29 |
8 |
p. 421-429 9 p. |
artikel |
2 |
Can drug removals involving cyclooxygenase-2 inhibitors be avoided? A plea for human pharmacology
|
Hinz, Burkhard |
|
2008 |
29 |
8 |
p. 391-397 7 p. |
artikel |
3 |
Editorial Board
|
|
|
2008 |
29 |
8 |
p. i- 1 p. |
artikel |
4 |
Introducing GOAT: a target for obesity and anti-diabetic drugs?
|
Gualillo, Oreste |
|
2008 |
29 |
8 |
p. 398-401 4 p. |
artikel |
5 |
Location, location, location…site-specific GPCR phosphorylation offers a mechanism for cell-type-specific signalling
|
Tobin, Andrew B. |
|
2008 |
29 |
8 |
p. 413-420 8 p. |
artikel |
6 |
Multi-layered action mechanisms of CD137 (4-1BB)-targeted immunotherapies
|
Melero, Ignacio |
|
2008 |
29 |
8 |
p. 383-390 8 p. |
artikel |
7 |
Neuroinflammation and synaptic plasticity: theoretical basis for a novel, immune-centred, therapeutic approach to neurological disorders
|
Di Filippo, Massimiliano |
|
2008 |
29 |
8 |
p. 402-412 11 p. |
artikel |
8 |
Novel therapeutic targets for autism
|
Theoharides, Theoharis C. |
|
2008 |
29 |
8 |
p. 375-382 8 p. |
artikel |